The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The GH–IGF‐I axis and the cardiovascular system: clinical implications
Open accessAbstract
Summary: Background GH and IGF‐I affect cardiac structure and performance. In the general population, low IGF‐I has been associated with higher prevalence of ischaemic heart disease and mortality. Both in GH deficiency (GHD) and excess life expectancy has been reported to be reduced because of cardiovascular disease. Objective To review the role of the GH–IGF‐I system on the cardiovascular system. Results Recent epidemiological evidence suggests that serum IGF‐I levels in the low‐normal range are associated with increased risk of acute myocardial infarction, ischaemic heart disease, coronary and carotid artery atherosclerosis and stroke. This confirms previous findings in patients with acromegaly or with GH‐deficiency showing cardiovascular impairment. Patients with either childhood‐ or adulthood‐onset GHD have cardiovascular abnormalities such as reduced cardiac mass, diastolic filling and left ventricular response at peak exercise, increased intima‐media thickness and endothelial dysfunction. These abnormalities can be reversed, at least partially, after GH replacement therapy. In contrast, in acromegaly chronic GH and IGF‐I excess causes a specific cardiomyopathy: concentric cardiac hypertrophy (in more than two‐thirds of the patients at diagnosis) associated to diastolic dysfunction is the most common finding. In later stages, impaired systolic function ending in heart failure can occur, if GH/IGF‐I excess is not controlled. Abnormalities of cardiac rhythm and of cardiac valves can also occur. Successful control of acromegaly is accompanied by decrease of the left ventricular mass and improvement of cardiac function. Conclusion The cardiovascular system is a target organ for GH and IGF‐I. Subtle dysfunction in the GH–IGF‐I axis are correlated with increased prevalence of ischaemic heart disease. Acromegaly and GHD are associated with several abnormalities of the cardiovascular system and control of GH/IGF‐I secretion reverses (or at least stops) cardiovascular abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Sandhu, M. S., Heald, A. H., Gibson, J. M., Cruickshank, J. K., Dunger, D. B., & Wareham, N. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08655-5 · Cited by 470
Laughlin, G. A., Barrett-Connor, E., Criqui, M. H., & Kritz-Silverstein, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030967 · Cited by 374 · cited 1×
“14,15 Event References Authors 4 Incidence of IHD 10–12 Juul et al. 2002; Vasan et al. 2003, Laughlin et al. 2004 4 Incidence of stroke 13–15 Denti et al. 2004; Johnsen et al. 2005, Bondanelli et al. 2006 4 IMT 16,17 Van der Belt et al. 2003; Colao et al. 2005 4 BP and vascular tone 18,19 Gillespie…”
BackgroundCardiac structural and functional abnormalities in adult patients with growth hormone deficiency.
Merola, B., Cittadini, A., Colao, A., Longobardi, S., Fazio, S., Sabatini, D., Saccá, L., & Lombardi, G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263155 · Cited by 253
Self-citationEndothelial dysfunction in hypopituitary adults with growth hormone deficiency
Evans, M., Davies, Goodfellow, Rees, & Scanlon (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00671.x · Cited by 129
Cited by
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., De Ita, J. R., de la Garza, R. G., & Castilla-Cortazar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 295
Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review
Bergman, D., Halje, M., Nordin, M., & Engström, W. (2013) · Gerontology · doi:10.1159/000343995 · Cited by 260
Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men
Ochi, M., Kohara, K., Tabara, Y., Kido, T., Uetani, E., Ochi, N., Igase, M., & Miki, T. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.026 · Cited by 252
Metadata
- Authors
- Colao, A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2008-08-13
- Volume
- 69
- Issue
- 3
- Pages
- 347-358
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2014798423
- Cited by
- 209
- References
- 6
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The GH–IGF‐I axis and the cardiovascular system: clinical implications. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03292.x
- The paper
- Colao, A. (2008). The GH–IGF‐I axis and the cardiovascular system: clinical implications. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03292.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.